These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 468898)

  • 61. [Therapeutic effects of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) and radiation on the rat glioma (author's transl)].
    Mineura K; Mori T; Katakura R; Sasaki T
    No Shinkei Geka; 1981; 9(3):257-65. PubMed ID: 6941099
    [No Abstract]   [Full Text] [Related]  

  • 62. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
    Röhn TA; Wagenknecht B; Roth W; Naumann U; Gulbins E; Krammer PH; Walczak H; Weller M
    Oncogene; 2001 Jul; 20(31):4128-37. PubMed ID: 11464279
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Overcoming of ACNU resistance in an ACNU-resistant subline of rat C6 glioma in vivo through enhanced effect of ACNU by calmodulin inhibitor].
    Yoshida T; Shimizu K; Hayakawa T; Mogami H; Sakamoto Y; Egawa T
    No Shinkei Geka; 1987 Mar; 15(3):261-7. PubMed ID: 3474542
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Study of in vitro and in vivo effect of docosahexaenoic acid on rat C6 glioma.
    Nasrollahzadeh J; Siassi F; Doosti M; Eshraghian MR
    J Exp Ther Oncol; 2009; 8(2):95-103. PubMed ID: 20192116
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Poly(ADP-ribose) polymerase-independent potentiation of nitrosourea cytotoxicity by 3-aminobenzamide in human malignant glioma cells.
    Winter S; Weller M
    Eur J Pharmacol; 2000 Jun; 398(2):177-83. PubMed ID: 10854828
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Comparative studies on anti-tumor effects of nitrosoureas, ACNU and MCNU, on experimental brain tumors (author's transl)].
    Harada K; Kiya K; Okamoto H; Uozumi T
    Neurol Med Chir (Tokyo); 1981 Oct; 21(10):1017-23. PubMed ID: 6172720
    [No Abstract]   [Full Text] [Related]  

  • 67. [Monstrous cell in malignant gliomas--in relation to radiation and chemotherapy (author's transl)].
    Ogashiwa M; Takeuchi K; Akai K
    No To Shinkei; 1981 Jul; 33(7):733-42. PubMed ID: 7272101
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Myelofibrosis following treatment with a nitrosourea for malignant glioma.
    McKenney SA; Fehir KM
    Cancer; 1986 Oct; 58(7):1426-7. PubMed ID: 3742462
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Assay of anti-cancer drugs in tissue culture: relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma.
    Thomas DG; Darling JL; Paul EA; Mott TJ; Godlee JN; Tobias JS; Capra LG; Collins CD; Mooney C; Bozek T
    Br J Cancer; 1985 Apr; 51(4):525-32. PubMed ID: 3978031
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The reaction of the cancerostatic CCNU with the catalytic site of transglutaminase.
    Tarantino A; Thompson P
    Cancer Biochem Biophys; 1979; 4(1):33-6. PubMed ID: 40689
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Treatment of brain tumors with 1-(2 chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
    Takeuchi J; Nakao S; Handa H
    Nihon Geka Hokan; 1973 Apr; 42(2):184-9. PubMed ID: 4738478
    [No Abstract]   [Full Text] [Related]  

  • 72. Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.
    Levin VA; Kabra PA; Freeman-Dove MA
    Cancer Chemother Pharmacol; 1978; 1(4):233-42. PubMed ID: 750110
    [TBL] [Abstract][Full Text] [Related]  

  • 73. What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma.
    Amarasingh S; Macleod MR; Whittle IR
    J Neurooncol; 2009 Jan; 91(2):117-25. PubMed ID: 18813876
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Adriamycin and 1-(2-chlorethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the treatment of metastatic breast cancer.
    Waterfield WC; Tashima CK; Hortobagyi GN; Blumenschein GR; Buzdar AU; Burgess MA
    Cancer; 1978 Apr; 41(4):1235-9. PubMed ID: 638989
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential sensitivity of colony-forming cells of hemopoietic tissue, Lewis lung carcinoma, and B16 melanoma to three nitrosoureas.
    Blackett NM; Courtenay VD; Mayer SM
    Cancer Chemother Rep; 1975; 59(5):929-33. PubMed ID: 1203897
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sensitivity to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) of glioma cells in vivo and in vitro.
    Yoshida J; Shibuya N; Kobayashi T; Kageyama N
    Cancer; 1982 Aug; 50(3):410-8. PubMed ID: 6953989
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
    Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
    Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chemotherapeutic effects of some alkylating derivatives of nitrosourea on the development of tumors transplacentally induced in rats by ENU.
    Schiffer D; Giordana MT; Pezzotta S; Paoletti P
    Acta Neuropathol; 1976 Jan; 34(1):21-31. PubMed ID: 175631
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Animal model for liver dysfunction using lomustine in Wistar rats.
    Tiwari BP; Ramanathan P; Patel RB; Raste AS; Gadre SG; Soman CS; Deodhar KK
    Indian J Gastroenterol; 2000; 19(1):9-11. PubMed ID: 10659479
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance.
    Levin VA; Prados MD
    J Clin Oncol; 1992 May; 10(5):766-71. PubMed ID: 1314890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.